Info: Read More
  • 中药标准品生产商,产品定制服务
  • 8-O-乙酰山栀苷甲酯

    8-O-Acetylshanzhiside methyl ester

    8-O-乙酰山栀苷甲酯
    产品编号 CFN98966
    CAS编号 57420-46-9
    分子式 = 分子量 C19H28O12 = 448.4
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Iridoids
    植物来源 The herbs of Lamiophlomis rotata (Benth.) Kudo.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    8-O-乙酰山栀苷甲酯 CFN98966 57420-46-9 10mg QQ客服:1457312923
    8-O-乙酰山栀苷甲酯 CFN98966 57420-46-9 20mg QQ客服:1457312923
    8-O-乙酰山栀苷甲酯 CFN98966 57420-46-9 50mg QQ客服:1457312923
    8-O-乙酰山栀苷甲酯 CFN98966 57420-46-9 100mg QQ客服:1457312923
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • Institute of Chinese Materia Medica (China)
  • Charles University in Prague (Czech Republic)
  • University Medical Center Mainz (Germany)
  • Aveiro University (Portugal)
  • University of Oslo (Norway)
  • Uniwersytet Medyczny w ?odzi (Poland)
  • University of the Basque Country (Spain)
  • University of Queensland (Australia)
  • Rio de Janeiro State University (Brazil)
  • University of Maryland (USA)
  • Helmholtz Zentrum München (Germany)
  • National Research Council of Canada (Canada)
  • Institute of Bioorganic Chemistry Polish Academy of Sciences (Poland)
  • Leibniz-Institut für Pflanzenbiochemie (IPB) (Germany)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • J Holistic Integrative Pharm.2023, 4(1):14-28
  • J Cell Biochem.2018, 119(2):2231-2239
  • J. of Med. Plant Research.2013, 90-151
  • Saudi Pharm J2020, 10.1016
  • Journal of Life Science2018, 917-922
  • Front Immunol.2023, 14:1240800.
  • Sci Rep.2020, 10:4495(2020)
  • LWT2020, 110397
  • Phytochem Anal.2021, 32(6):970-981.
  • Cancers (Basel).2021, 13(9):2223.
  • Molecules.2022, 27(4):1412.
  • Curr Issues Mol Biol.2022, 44(5):2300-2308.
  • Acta Pharm Sin B.2015, 5(4):323-9.
  • Asian Journal of Chemistry2014, 26(8):2425
  • Analytical methods2019, 11(6)
  • Oxid Med Cell Longev.2021, 2021:6647107.
  • Vietnam Journal of Food Control2022, 5(3):pp.390-401.
  • Biosci Rep.2018, 38(4)
  • Nutrients.2022, 14(16):3393.
  • Plant Foods Hum Nutr.2021, 76(4):472-477.
  • Molecules.2023, 28(19):6775.
  • Front Plant Sci.2022, 13:982771.
  • Heliyon2020, 6(6):e04337.
  • ...
  • 生物活性
    Description: 8-O-Acetylshanzhiside methyl ester(ND01) has potential against cerebral ischemic injury and experimental myocardial ischemia injury, it can increase angiogenesis and improve functional recovery after stroke. ND01 protects diabetic brain against I/R injury by alleviating diabetic cerebral I/R injury and attenuating blood–brain barrier (BBB) breakdown, and its protective effects may involve HMGB-1 and NF-κB signalling pathway.
    Targets: TNF-α | NF-kB | VEGFR | Akt | Calcium Channel | Caspase
    In vitro:
    Eur J Pharm Sci. 2012 Aug 30;47(1):124-30.
    Cardioprotection with 8-O-acetylshanzhiside methylester on experimental myocardial ischemia injury.[Pubmed: 22677812 ]
    8-O-acetylshanzhiside methyl ester (ND01) was isolated from the leaves of Lamiophlomis rotata (Benth.) Kudo. In this study, we investigated the anti-myocardial ischemia and reperfusion (I/R) injury effects of ND01 in vivo and elucidated the potential mechanism in vitro.
    METHODS AND RESULTS:
    The results indicated that ND01 significantly attenuated hypoxia-induced cytotoxicity in a concentration-dependent manner in H9c2 cells. Treatment of H9c2 cells with ND01 9 μM blocked TNF-α-induced nuclear factor kappaB (NF-κB) phosphorylation by blocking High-mobility group box1 (HMGB1) expression. Treatment of rats with ND01 10mg/kg, (i.v.) protected the animals from myocardial I/R injury as indicated by a decrease in infarct volume, improvement in hemodynamics and reduction of myocardial damage severity. Treatment with ND01 also lowered serum levels of pro-inflammatory factors and reduced High mobility group box-1 protein (HMGB1) and phosphorylated NF-κB expression in ischemic myocardial tissue. Additionally, continuous i.v. of ND01 14 days attenuated cardiac remodeling.
    CONCLUSIONS:
    These protective effects suggested that ND01 might be due to block of myocardial inflammatory cascades through an HMGB1-dependent NF-κB signaling pathway.
    In vivo:
    Basic Clin Pharmacol Toxicol. 2011 Jan;108(1):21-7.
    Effect of 8-O-acetyl shanzhiside methylester increases angiogenesis and improves functional recovery after stroke.[Pubmed: 20735376]
    We investigated whether 8-O-acetylshanzhiside methyl ester (ND01) regulates angiogenesis and thereby improves functional outcome after stroke.
    METHODS AND RESULTS:
    Adult male rats were subjected to 1 hr of middle cerebral artery occlusion (MCAO) and reperfusion, and treated with or without different doses (5 and 10 mg/kg) of ND01, starting 24 hr after ischaemia and reperfusion (I/R) and by intravenous injection daily for 14 days. Neurological functional tests were performed and cerebral Evans blue extravasation was measured. Angiogenesis and angiogenic factor expression were measured by immunohistochemistry and Western blot, respectively.
    CONCLUSIONS:
    The results indicated that ND01 significantly promoted angiogenesis in the ischaemic brain and improved functional outcome after stroke. ND01 also significantly increased vascularization compared with vehicle treatment. ND01 increased the expression of VEGF, Ang1, phosphorylation of Tie2 and Akt VEGF. The Ang1/Tie2 axis and Akt pathways appear to mediate ND01-induced angiogenesis.
    J Ethnopharmacol . 2016 Jul 1;187:232-8.
    A new anti-fibrinolytic hemostatic compound 8-O-acetyl shanzhiside methylester extracted from Lamiophlomis rotata[Pubmed: 27085939]
    Abstract Background: Fibrinolysis prevents blood clots from growing and becoming problematic. Antifibrinolytics are used as inhibitors of fibrinolysis. Aprotinin was doubted after identification of major side effects, especially on kidney. Lysine analogues has their own defects and whether they are adequate substitutes for aprotinin is still under doubt. Lamiophlomis rotata (Benth.) Kudo. was previous found to have hemostatic activity. But the active compound in L. rotata and its hemostatic mechanism were unknown. Objectives: To find the major hemostatic compound in L. rotata and identify its haemostasis mechanism. Methods: Traumatic hemorrhage model and coagulant activity assays were monitored in mice and platelets in drug treatment group and control group. Hyperfibrinolysis model was established by intravenous administration of urokinase in mice. Capillary blood clotting time (CBCT), activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), fibrinogen and euglobulin clot lysis time (ECLT) were measured. Results: The anti-fibrinolytic activity come from 8-O-Acetyl shanzhiside methylester (ASM) one of the highest iridoid glycosides contents in TIG extracted from L. rotata. ASM significantly (P<0.05) shorten CBCT and reduced blood loss volume in vivo, but did not influence mice APTT, PT or TT. In particular, it significantly prolonged ECLT in hyperfibrinolysis mice. It indicated that ASM could inhibit fibrinolysis. ASM was also effective in CBCT, traumatic bleeding volume and ECLT in hyperfibrinolysis mice model. Conclusions: ASM was the major hemostatic compound in L. rotata. The haemostasis mechanism of ASM was achieved by anti-fibrinolytic activity. ASM was a new fibrinolysis inhibitor as iridoid glycoside compound. Keywords: Antifibrinolytics; Bleeding volume; Hemostatics; Hyperfibrinolysis; Iridoid glycosides.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.2302 mL 11.1508 mL 22.3015 mL 44.603 mL 55.7538 mL
    5 mM 0.446 mL 2.2302 mL 4.4603 mL 8.9206 mL 11.1508 mL
    10 mM 0.223 mL 1.1151 mL 2.2302 mL 4.4603 mL 5.5754 mL
    50 mM 0.0446 mL 0.223 mL 0.446 mL 0.8921 mL 1.1151 mL
    100 mM 0.0223 mL 0.1115 mL 0.223 mL 0.446 mL 0.5575 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    山栀苷甲酯; Shanzhiside methylester CFN97107 64421-28-9 C17H26O11 = 406.4 20mg QQ客服:1457312923
    8-O-乙酰山栀苷甲酯; 8-O-Acetylshanzhiside methyl ester CFN98966 57420-46-9 C19H28O12 = 448.4 20mg QQ客服:1457312923
    (E)-6-O-对香豆酰鸡屎藤次苷甲酯; (E)-6-O-(p-coumaroyl)scandoside methyl ester CFN95192 83946-90-1 C26H30O13 = 550.5 10mg QQ客服:2159513211
    6-O-反式对香豆酰山栀苷甲酯; 6-O-trans-p-Coumaroylshanzhiside methyl ester CFN99359 1246012-26-9 C26H32O13 = 552.5 5mg QQ客服:1413575084
    6Beta-野芝麻新甙; 6beta-Hydroxyipolamiide CFN97445 87797-84-0 C17H26O12 = 422.4 5mg QQ客服:215959384
    环烯醚萜B; Phlorigidoside B CFN98356 288248-46-4 C19H28O13 = 464.4 5mg QQ客服:2159513211
    6-O-苯甲酰环烯醚萜B; 6-O-Benzoylphlorigidoside B CFN99357 1246012-24-7 C26H32O14 = 568.5 5mg QQ客服:2159513211
    6-O-trans-Cinnamoylphlorigidoside B; 6-O-trans-Cinnamoylphlorigidoside B CFN99358 1246012-25-8 C28H34O14 = 594.6 5mg QQ客服:1413575084

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产